News
The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe's most intricate and ...
INmune Bio's XPro shows promise in early AD despite missed endpoints. Click here to find out why I rate INMB stock is a Hold.
Ketamine has been making headlines for years, from the death of actor Matthew Perry to Elon Musk's reported microdosing, to its portrayal in Hulu's "The Secret Lives of Mormon Wives." ...
Substance use and substance use disorder (formerly substance abuse) differ by the frequency of use and the effect on a person ...
Summary: New research reveals how a tiny chemical mark on RNA helps wire the brain during development. Scientists discovered ...
In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed these medications were 50% less likely to binge drink. The results were ...
GRIN-related neurodevelopmental disorder (GRIN-NDD) is a family of rare, genetically defined neurodevelopmental disorders ...
Addex Therapeutics (SIX: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small ...
Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...
Ibogaine is illegal in the U.S., but growing evidence shows its promise treating the effects of traumatic brain injury and substance use disorder.
A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results